pharmaceuticals
Molecular spectroscopy market to be valued at $6.4b by 2034
Molecular spectroscopy market to be valued at $6.4b by 2034
Key sectors include pharmaceuticals and biotechnology.
10 minutes ago
mRNA vaccine venture financing plunges 82%to $90m in 2025 YTD
The decline follows a $500m cut in grant support by the US HHS.
1 day ago
New Zealand to ease pharmacy ownership rules under forthcoming Bill
Community pharmacies will no longer need to be mostly owned by registered pharmacists.
Cardiovascular drugs market to be valued at $247.8b by 2033
Better patient awareness and personalised therapies are driving growth.
Redcliffe Hospital trials new tech for precise antibiotic dosing
It uses data and computer modelling combined with blood test results.
Vaccines market to be valued at $63.7b by 2030
Its expansion is attributed to rapid development and commercialisation.
India launches index to benchmark state drug regulatory systems
SHRESTH will track parameters such as laboratory testing capacities.
Biologic therapeutic market to hit $794.5b by 2029
Thanks to the demand for monoclonal antibodies, gene and cell therapies, and vaccines.
China leads in clinical trials outside North America and Europe in Q2
Meanwhile, India overtook Iran to claim second place.
Pakistan’s drug import dependence poses risks to critical medicine supply
Pharmaceutical imports are expected to reach $920m by 2029.
Abu Dhabi and Abbott partner to localise pharmaceutical manufacturing
One key area is the development of biosimilars.
KFSHRC, Germfree to launch modular ATMP manufacturing campus
The facility will be located at the hospital’s main campus in Riyadh.
Global biosimilars market to hit $72.3b by 2035
Thanks to the rising number of regulatory approvals.
India’s rising obesity cases open market opportunities for drugmakers
Diagnosed prevalent cases are expected to increase to 14.63 million in 2031.
India’s pharma industry to face ongoing scrutiny over quality issues
A recent FDA announcement presents risks for the country’s sector.
China’s biopharma sector strikes $30b in oncology licensing deals
Antibody-drug conjugates dominated licensing activity in 2024.
Global radiopharmaceuticals market to be valued at $12.2b by 2030
Its growth is attributed to a rise in cancer and cardiovascular diseases.
Most Read
1. Bulacan province unveils Philippines’ first locally funded MRI unit 2. InterSystems wins at Asian Innovation Excellence Awards 2025 for AI-powered EHR 3. Indonesia’s MedTech import market hit $3.28b in 2024 4. Narayana Health acquires UK-based Practice Plus Group Hospitals 5. APAC eyes fastest growth in global companion diagnostics marketResource Center
Read Here
Advertise
Sign Up
Awards
Mar
26
Events
Partner Events
Nov
12
Event News
The company’s IntelliCare™ solution transforms healthcare delivery through AI-powered efficiency and enhanced clinician experience.
